Industry Engagement

Working with Industry

Based in Ireland, we are the internationally-focused Science Foundation Ireland research center for chronic and rare neurological disease linking innovative neurotherapeutics development with genomic and biomarker-based patient stratification enabled by a national eHealth infrastructure. We connect SME and multinational industry partners with leading Irish scientists in neurological investigation and a research-active clinical network to design and deliver patient-centred translational research.

=

Real-world data to inform molecular diagnostics and targeted therapeutics

=

Genomic diagnostics

=

Technology for rapid point-of-care diagnostics

=

Neuronal stem cell technology to discover drug treatments

=

Novel screening models for disease modifying treatments

=

Companion nanotechnology solutions for the delivery of therapies to affected brain region

=

eHealth technology for improved care pathways

=

Gene therapy, large molecules across the blood brain barrier

=

Immuno-neuroprotection

=

Basic mechanisms of neurological disease

=

RNA-targeting therapeutics to restore normal brain excitability

=

Precision medicines and infrastructure for translation to the clinic

=

Molecular biomarkers for acquired and rare, genetically-defined epilepsies and Motor Neurone Disease

Our areas of expertise  

With our core skills in neuroscience, clinical neurology, genetics, cell biology, materials chemistry, patient care and patient data analytics across seven academic institutions we bring expertise in a number of areas.

Through our academic and clinical partners, we have access to state-of-the-art research infrastructure. Our ability to combine and apply these technologies across our themes of Diagnosis, Therapeutics and eHealth makes us distinctive and excellent.

Key enablers for our translational research  

$

Clinical network

$

Platform technologies

$

Clinical trials

$

Biosamples and Biobanking

$

Disease models

$

International network

$

Disease registers

Engaging with FutureNeuro

We invite partnerships with SMEs and multinational pharmaceutical and biomedical companies in sectors covering:

  • digital and biological biomarkers
  • diagnostic tools
  • therapeutic discovery and development
  • eHealth-enabled patient support platforms
  • clinical trials.

Partnering opportunities with us can include:

  • Fully-funded collaborations
  • Jointly-funded collaborations
  • Joint applications for research funding (eg. H2020, NIH)
  • Participation in national Centre expansion programmes (e.g. DTIF, BESTS)

We have in-depth experience in industry engagement, technology transfer, IP management and commercialisation. We work closely with the relevant State Agencies and can support partners to obtain appropriate state funding mechanisms.

To discuss a research partnership with  FutureNeuro, please contact:

Bridget Doyle  Business Development and Centre Manager  t:   +353 1 402 5061 m:  +353 87 683 7203 e:  bridgetdoyle@rcsi.ie

Hover to see our partners 

Our current projects with industry partners focus on bringing diagnostic supports to market, developing and testing pipeline of new drugs, and expanding connected health solutions to enable patients and their clinicians co-monitor their health better than ever before.

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Ulysses Neuroscience Logo

Eisai Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo